Search

Separation is crucial for recycling heavy metals, however, most of the reported processes focus on separating metals from non-metals. Here we propose a magnetic levitation (MagLev) configuration to separate heavy metals from metallic mixtures. The novel configuration is able to levitate substances with specific densities over 5.00 g/cm3, while the extant MagLev devices can only handle materials that have specific densities no more than 3.00 g/cm3. We mathematically model the proposed MagLev configuration and apply the approach to separate rare earth metals from fluorescent powders as well as indium contents from indium-tin oxide (ITO)/glass mixtures, mechanically processed liquid crystal displays (LCDs) and ITO powder. The results show that the recovery rates of ITO from ITO/glass mixtures are over 95%, the concentrations of indium in separated LCD shreds are doubled (from 912.0 ppm to 1873.1 ppm), and the purities of separated In2O3 from ITO powder are around 90%. The method is controllable and requires no energy or chemical inputs, and it thereby has tremendous prospects in heavy metal recycling.

To compare the effectiveness of neostigmine induced reversal of rocuronium in neonates, infants, young children and children.One hundred and sixty ASA I or II pediatric patients undergoings elective surgical procedures under total intravenous anesthesia were enrolled during July 2014 to April 2015 in Tianjin Children's Hospital. The patients were divided into four groups according to ages: neonate group, infant group, young children group and children group.Then control subgroup and neostigmine reversal subgroup including twenty patients were randomly selected from every different age groups by the method of random number table. After induction of anesthesia, 0.6 mg/kg rocuronium was administered, and 0.2 mg/kg maintenance doses given as required during period of operation. Neuromuscular block was monitored using acceleromyographic train of four (TOF). When T1/control returned to 15%, 0.03 mg/kg neostigmine and 0.01 mg/kg atropine were given to patients of reversal subgroups, and saline 0.1 ml/kg was given to patients of control subgroups. The recovery time of T25, T75, TR0.7, recovery index, blood pressure, heart rate and adverse reactions were observed and recorded.In control subgroups, the recovery time of T75 for neonates, infants, young children and children were (27.10±8.72), (16.70±6.35), (13.05±1.96), (14.40±3.08) min, respectively (F=25.052, P0.01). The recovery time of TR0.7 were (27.75±8.56), (18.45±5.62), (14.95±2.64), (15.70±3.36) min, respectively (F=22.496, P0.01). The recovery index were (20.75±7.09), (12.40±5.04), (10.01±2.00), (10.55±2.82) min, respectively (F=22.725, P0.01). There were no significant difference for the every recovery time and recovery index between infants, young children and children (all P0.05). But the recovery time of T75, TR0.7 and recovery index in neonate group were longer than other age groups (all P0.01). In reversal subgroups , the recovery time of T75 for neonates, infants, young children and children were (14.05±3.54), (8.08±3.08), (6.53±0.98), (7.10±1.54) min, respectively (F=37.947, P0.01). The recovery time of TR0.7 were (14.95±3.19), (9.32±3.44), (7.45±1.40), (8.12±1.67) min, respectively (F=34.744, P0.01). The recovery index were (11.05±3.26), (5.96±2.46), (4.99±0.95), (5.22±1.39) min, respectively (F=33.542, P0.01). The recovery time of T75, TR0.7 and recovery index were delayed in neonates compared with other age groups (all P0.01). Haemodynamics were stable in all groups before or after giving antagonist, and no significant adverse reactions were observed.The spontaneous recovery time after administrating rocuronium are comparable in infant, young children and children. There are obviously reversal effects in all of age groups when neostigmine is given to antagonize rocuronium. Either spontaneous recovery time or reversal recovery time of neostigmine to rocuronium is longer for neonates than other age's children.